An update from Indivior ( (GB:INDV) ) is now available.
Indivior PLC announced that Vishal Kalia, Chief Strategy and Operating Officer, purchased 2,262 ordinary shares at an average price of $8.87 per share, and Nisha Jairath, associated with Kalia, acquired 1,261 shares at £7.01 each. These transactions, conducted on February 28, 2025, reflect a significant personal investment by a key executive and associated person, potentially indicating confidence in the company’s future performance.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and commercialization of medications for the treatment of addiction and other mental health disorders. Its primary products include treatments for opioid dependence and schizophrenia, with a market focus on providing innovative solutions for addiction recovery.
YTD Price Performance: -29.44%
Average Trading Volume: 324,548
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £900.6M
See more insights into INDV stock on TipRanks’ Stock Analysis page.